mice
play
central
role
biomed
research
includ
infecti
diseas
easili
access
versatil
anim
model
abund
knowledg
genet
promot
use
model
system
mani
human
virus
howev
infect
mice
although
murin
virus
mous
herpesviru
relat
epsteinbarr
viru
ebv
kaposi
sarcomaassoci
herpesviru
kshv
murin
cytomegaloviru
cmv
homolog
human
cmv
consid
model
human
virus
consider
divers
biolog
activ
pathogenesi
murin
human
virus
introduct
transgen
encod
viru
receptor
mice
enabl
virus
adenovirus
measl
viru
coronaviru
hepat
c
viru
infect
mice
approach
remov
speci
barrier
mani
virus
includ
human
immunodefici
viru
breakthrough
issu
brought
develop
scidhu
thyliv
mous
scidhu
pbl
mous
base
scid
mous
due
mutat
gene
code
subunit
dnadepend
protein
kinas
essenti
recombin
tcell
bcell
receptor
gene
mice
lack
b
cell
abil
reject
human
tissu
cell
scidhu
thyliv
mice
prepar
transplant
tissu
human
fetal
thymu
liver
renal
capsul
scid
mice
allow
de
novo
gener
human
cell
includ
compart
scidhu
thyliv
mice
primarili
use
vivo
model
infect
target
mainli
cell
monocytesmacrophag
addit
scidhu
thyliv
mice
use
model
human
herpesviru
human
cytomegaloviru
kaposi
sarcomaassoci
herpesviru
kshv
infect
measl
viru
varicellazost
viru
variou
key
featur
human
infect
includ
select
deplet
cell
reproduc
scidhu
thyliv
mice
scidhu
pbl
mice
hand
prepar
transplant
human
peripher
blood
mononuclear
cell
pbmc
periton
caviti
scid
mice
effici
engraft
compon
human
immun
system
includ
b
cell
observ
scidhu
pbl
mice
use
model
human
tlymphotrop
viru
ebv
infect
recapitul
mani
featur
pathogenesi
howev
limit
earlygener
human
mous
model
human
lymphocyt
gener
scidhu
thyliv
mice
distribut
system
therefor
intrathym
intranod
inocul
necessari
viru
infect
mostli
confin
inocul
organ
scidhu
pbl
mice
prone
graft
versu
host
diseas
scidhu
thyliv
scidhu
pbl
mice
mount
primari
immun
respons
virus
disadvantag
overcom
newgener
human
mice
develop
decad
newgener
human
mice
prepar
transplant
human
hematopoiet
stem
cell
hsc
mice
variou
sever
immunodefici
strain
eg
nodshiscid
null
nog
balbc
brg
nodltszscid
nsg
major
compon
human
immun
system
includ
cell
b
cell
nk
cell
dendrit
cell
monocytesmacrophag
reconstitut
one
protocol
blt
bone
marrow
liver
thymu
mous
tissu
human
fetal
liver
thymu
well
hsc
deriv
liver
transplant
enabl
proper
intrathym
select
human
cell
newgener
human
mice
infect
ebv
dengu
viru
herp
simplex
viru
type
kaposi
sarcomaassoci
herpesviru
kshv
addit
human
mice
provid
opportun
analyz
human
antiinfluenza
viru
immun
respons
mice
although
infect
influenza
viru
per
se
feasibl
regular
mice
besid
immun
systemhuman
mice
immunodefici
mice
harbor
function
human
hepatocyt
develop
shown
excel
model
hepat
b
c
viru
infect
pathogenesi
furthermor
human
mice
harbor
human
hepatocyt
human
immun
system
compon
prepar
could
reproduc
hcvspecif
immun
respons
pathogenesi
variou
immunodefici
mous
strain
use
vivo
model
human
viru
infect
summar
tabl
review
focu
human
mous
model
ebv
infect
especi
newgener
human
mous
model
describ
util
reproduct
key
featur
human
ebv
infect
includ
pathogenesi
immun
respons
latent
infect
applic
model
includ
preclin
studi
therapeut
strategi
also
discuss
ebv
ubiquit
lymphotrop
herpesviru
infect
adult
popul
world
although
primari
ebv
infect
childhood
mostli
asymptomat
adolesc
young
adult
result
infecti
mononucleosi
im
least
case
whether
accompani
im
ebv
infect
result
lifelong
persist
infect
restrict
fraction
host
ebv
etiolog
involv
varieti
diseas
includ
lymphoprolif
diseas
lpd
immunocompromis
patient
posttranspl
lymphoprolif
diseas
ptld
aidsassoci
lymphoma
malign
lymphoma
endem
burkitt
lymphoma
hodgkin
lymphoma
epitheli
malign
nasopharyng
carcinoma
gastric
carcinoma
tnkcell
lpd
chronic
activ
ebv
infect
caebv
ebvassoci
hemophagocyt
lymphohistiocytosi
ebvhlh
addit
substanti
evid
although
larg
indirect
present
accumul
implic
ebv
pathogenesi
autoimmun
diseas
rheumatoid
arthriti
ra
multipl
sclerosi
list
ebvassoci
diseas
present
tabl
ebvassoci
diseas
show
uneven
geograph
distribut
ebvposit
burkitt
lymphoma
endem
equatori
africa
new
guinea
nasopharyng
carcinoma
highli
preval
southern
china
ebvassoci
tnk
lpd
particularli
preval
east
asia
nativ
central
south
america
parot
carcinoma
endem
alaskan
inuit
obvious
etiolog
cofactor
addit
ebv
environment
host
factor
involv
pathogenesi
ebvassoci
diseas
although
major
still
unknown
ebv
uniqu
biolog
activ
transform
human
b
lymphocyt
lymphoblastoid
cell
line
lcl
capac
indefinit
prolifer
cultur
ebvtransform
lymphoblast
readili
remov
virusspecif
cytotox
lymphocyt
ctl
imunocompet
host
immunocompromis
host
like
transplant
recipi
aid
patient
howev
transform
cell
may
prolifer
unlimitedli
caus
bcell
lpd
ptld
aidsassoci
lymphoma
ebv
genom
encod
gene
nine
protein
ebv
nuclear
antigen
ebna
lp
latent
membran
protein
lmp
two
set
untransl
rna
ebvencod
small
rna
eber
bamhia
rightward
transcript
bart
express
b
lymphoblastoid
cell
transform
ebv
part
latentcycl
ebv
protein
rna
express
ebvassoci
malign
lpd
pattern
ebv
gene
express
classifi
three
type
latenc
character
express
eber
bart
seen
burkitt
lymphoma
gastric
carcinoma
gastric
carcinoma
express
addit
latenc
ii
character
express
eber
bart
found
caebv
hodgkin
lymphoma
nasopharyng
carcinoma
latenc
iii
character
express
nine
ebv
protein
two
set
ebv
rna
express
lcl
seen
ptld
aidsassoci
lymphoma
ebv
natur
infect
human
report
infect
cottontop
tamarin
common
marmoset
owl
monkey
rabbit
experiment
set
cottontop
tamarin
develop
bcell
lymphoma
follow
inocul
ebv
efficaci
candid
vaccin
viru
evalu
model
spite
potenti
valu
vivo
model
human
ebv
infect
endang
speci
use
larg
number
rhesu
monkey
lymphocryptoviru
highli
homolog
ebv
shown
reproduc
key
featur
human
ebv
infect
upon
primari
infect
naiv
monkey
includ
oral
transmiss
atyp
lymphocytosi
lymphadenopathi
express
bcell
activ
marker
peripher
blood
sustain
antibodi
respons
viral
protein
anim
model
thu
made
signific
contribut
studi
ebv
pathogenesi
treatment
although
disadvantag
common
primat
model
limit
access
high
cost
intrins
differ
rhesu
lymphocryptoviru
ebv
need
also
consid
mous
model
ebv
infect
avail
develop
scidhu
pbl
mice
sinc
major
target
ebv
lymphocyt
human
mice
readili
infect
viru
ebv
actual
first
human
viru
shown
infect
newgener
human
mice
describ
ebv
induc
bcell
lpd
immunocompromis
patient
frequent
histolog
type
ptld
aidsassoci
lymphoma
diffus
larg
bcell
lymphoma
dlbcl
although
smaller
number
burkitt
lymphoma
hodgkin
lymphoma
also
seen
recapitul
ebvinduc
bcell
lpd
mice
first
attain
scidhu
pbl
mice
scid
mice
transplant
intraperiton
pbmc
ebvseroposit
donor
develop
acut
bcell
lymphoma
subsequ
analys
indic
lymphoma
cell
ebvposit
express
consist
latenc
iii
program
ebv
gene
express
histolog
examin
immunohistochem
stain
surfac
marker
show
lymphoma
scidhu
pbl
mice
similar
repres
type
ptld
aidsassoci
lymphoma
transplant
pbl
ebvseroneg
donor
contrast
induc
lymphoma
follow
inocul
ebv
similar
lymphoma
dlbcl
histolog
induc
expect
transplant
establish
ebvtransform
lcl
also
induc
similar
bcell
lpd
scid
mice
studi
scidhu
pbl
mice
provid
valuabl
insight
mechan
ebvinduc
lymphoprolifer
vivo
exampl
engraft
ebvinfect
b
cell
scidhu
pbl
mice
found
depend
copres
uninfect
cell
suggest
essenti
role
vivo
prolifer
surviv
ebvtransform
cell
involv
human
signal
ebvassoci
lymphomagenesi
elucid
scidhu
pbl
mous
model
analysi
gene
polymorph
indic
aa
genotyp
base
preval
pbl
induc
aggress
lymphoprolifer
scidhu
pbl
mice
biolog
analysi
allel
adenosin
associ
ineffici
ctl
restimul
may
explain
find
earli
human
mous
model
bcell
lpd
howev
number
limit
first
ebvspecif
immun
respons
detect
mice
therefor
investig
immunosurveil
ebvassoci
lpd
feasibl
second
possibl
vari
condit
viral
infect
includ
dose
rout
inocul
third
analys
process
lymphomagenesi
start
viral
inocul
develop
lymphoma
possibl
mean
overcom
difficulti
provid
newgener
human
mice
prepar
transplant
human
hsc
immunodefici
mice
variou
strain
model
ebv
infect
base
newgener
human
mice
featur
human
ebv
infect
reproduc
summar
tabl
upon
infect
ebv
mice
develop
ebvposit
lymphoprolifer
variou
extent
yajima
other
character
ebvinduc
bcell
lpd
human
nog
hunog
mice
determin
variou
condit
lymphomagenesi
show
ebv
dose
transform
dose
tend
caus
lpd
wherea
less
predominantli
induc
asymptomat
persist
infect
express
demonstr
bcell
lpd
indic
latenc
iii
type
ebv
gene
express
immunohistochemistri
show
express
bcell
activ
marker
find
combin
observ
dlbcl
histolog
indic
ebvassoci
lpd
close
resembl
ptld
aidsassoci
lymphoma
reproduc
human
mice
interestingli
hodgkinlik
cell
mark
nucleoli
reedsternberglik
cell
multipl
nuclei
observ
primari
ebvposit
dlbcl
occasion
seen
model
ebvassoci
lpd
ebvassoci
bcell
lpd
similar
characterist
also
reproduc
human
nsg
hunsg
mice
blt
nsg
mice
one
earliest
work
ebv
infect
newgener
human
mice
use
nodscid
mice
transplant
human
hsc
reconstitut
b
cell
myeloid
cell
cell
demonstr
ebvposit
lpd
gener
mice
therefor
consid
develop
without
influenc
tcell
immunosurveil
ebv
gene
express
latenc
ii
type
observ
work
ebvassoci
lpd
reproduc
human
mice
excel
target
preclin
studi
experiment
therapi
number
drug
candid
experiment
therapi
includ
autolog
ebvspecif
ctl
nk
cell
antibodi
rituximab
combin
gmcsf
combin
lowdos
combin
antibodi
specif
antibodi
autolog
cell
evalu
use
scidhu
pbl
mice
ebvposit
lpd
one
studi
use
nodscid
mice
transplant
pbmc
without
plasmacytoid
dendrit
cell
deplet
show
import
role
cell
cellular
immun
respons
ebvassoci
lpd
express
thymidin
kinas
ebvtransform
lcl
cell
transplant
scid
mice
enabl
complet
regress
transplant
cell
administr
ganciclovir
use
nsg
mice
reconstitut
human
hsc
deriv
fetal
liver
gurer
other
demonstr
effect
target
endocyt
receptor
dendrit
cell
prepar
fusion
protein
carboxi
terminu
heavi
chain
antibodi
show
vaccin
fusion
protein
prime
secret
cell
induc
antibodi
hemophagocyt
lymphohistiocytosi
hlh
seriou
hyperinflammatori
condit
caus
highli
activ
ineffect
immun
respons
clinic
featur
hlh
mostli
caus
overproduct
cytokin
cell
macrophag
includ
fever
hepatosplenomegali
pancytopenia
hypertriglyceridemia
coagulopathi
hypofibrinogenemia
liver
dysfunct
ebvhlh
common
severest
type
virusassoci
hlh
character
monoclon
oligoclon
prolifer
ebvinfect
often
nk
cell
overproduct
cytokin
ebvinfect
cell
well
activ
macrophag
cell
react
viru
thought
play
central
role
pathogenesi
sato
other
report
exagger
tcell
respons
accompani
cytokinemia
ebvinfect
hunog
mice
contrast
earlier
find
obtain
ebvinfect
hunog
mice
observ
obviou
ebvposit
lpd
ebv
infect
restrict
b
cell
express
lyticcycl
gene
demonstr
cell
activ
phenotyp
infiltr
major
organ
includ
liver
spleen
mice
exhibit
normocyt
anemia
thrombocytopenia
base
find
togeth
find
hemophagocytosi
bone
marrow
tissu
suggest
ebvinfect
hunog
mice
might
use
experiment
model
ebvhlh
although
ebvhlh
usual
associ
ebvinduc
prolifer
nk
cell
result
suggest
ebv
infect
b
cell
may
also
caus
similar
hlh
inde
ebvhlh
develop
patient
xlink
lymphoprolif
diseas
prolifer
ebvinfect
b
cell
observ
use
hunog
mice
yajima
other
observ
predominantli
bcell
lpd
fact
number
differ
protocol
sato
et
al
yajima
et
al
may
explain
differ
result
exampl
although
group
use
cord
bloodderiv
hsc
former
inject
hsc
newborn
male
mice
intrahepat
wherea
latter
use
weekold
femal
mice
employ
intraven
rout
time
viru
infect
transplant
hsc
import
factor
determin
level
tcell
develop
may
also
influenc
outcom
ebv
infect
human
mice
describ
xenogen
transplant
pbmc
obtain
patient
ebvhlh
nog
mice
also
reproduc
cardin
featur
ebvhlh
hemophagocyt
lymphohistiocytosi
hlh
seriou
hyperinflammatori
condit
caus
highli
activ
ineffect
immun
respons
clinic
featur
hlh
mostli
caus
overproduct
cytokin
cell
macrophag
includ
fever
hepatosplenomegali
pancytopenia
hypertriglyceridemia
coagulopathi
hypofibrinogenemia
liver
dysfunct
ebvhlh
common
severest
type
virusassoci
hlh
character
monoclon
oligoclon
prolifer
ebvinfect
often
nk
cell
overproduct
cytokin
ebvinfect
cell
well
activ
macrophag
cell
react
viru
thought
play
central
role
pathogenesi
sato
other
report
exagger
tcell
respons
accompani
cytokinemia
ebvinfect
hunog
mice
contrast
earlier
find
obtain
ebvinfect
hunog
mice
observ
obviou
ebvposit
lpd
ebv
infect
restrict
b
cell
express
lyticcycl
gene
demonstr
cell
activ
phenotyp
infiltr
major
organ
includ
liver
spleen
mice
exhibit
normocyt
anemia
thrombocytopenia
base
find
togeth
find
hemophagocytosi
bone
marrow
tissu
suggest
ebvinfect
hunog
mice
might
use
experiment
model
ebvhlh
although
ebvhlh
usual
associ
ebvinduc
prolifer
nk
cell
result
suggest
ebv
infect
b
cell
may
also
caus
similar
hlh
inde
ebvhlh
develop
patient
xlink
lymphoprolif
diseas
prolifer
ebvinfect
b
cell
observ
use
hunog
mice
yajima
other
observ
predominantli
bcell
lpd
fact
number
differ
protocol
sato
et
al
yajima
et
al
may
explain
differ
result
exampl
although
group
use
cord
bloodderiv
hsc
former
inject
hsc
newborn
male
mice
intrahepat
wherea
latter
use
weekold
femal
mice
employ
intraven
rout
time
viru
infect
transplant
hsc
import
factor
determin
level
tcell
develop
may
also
influenc
outcom
ebv
infect
human
mice
describ
xenogen
transplant
pbmc
obtain
patient
ebvhlh
nog
mice
also
reproduc
cardin
featur
ebvhlh
rheumatoid
arthriti
ra
character
synovi
prolifer
destruct
bone
cartilag
tissu
common
autoimmun
diseas
associ
progress
disabl
system
complic
sinc
late
evid
accumul
suggest
possibl
involv
ebv
pathogenesi
autoimmun
diseas
ra
system
lupu
erythematosu
syndrom
multipl
sclerosi
evid
link
ebv
ra
includ
follow
patient
ra
circul
ebv
load
higher
healthi
control
ii
activ
cell
specif
ebv
frequent
detect
iii
larg
number
cell
specif
ebvencod
protein
present
affect
joint
iv
tcell
function
suppress
outgrowth
ebvinduc
b
cell
defici
v
larger
number
ebvinfect
b
cell
present
blood
compar
normal
control
furthermor
infect
ebv
express
eber
demonstr
synovi
cell
ra
lesion
line
evid
howev
circumstanti
direct
evid
causal
relationship
miss
primarili
lack
appropri
anim
model
recent
kuwana
other
made
histopatholog
analys
joint
ebvinfect
hunog
mice
recogn
eros
arthriti
massiv
synovi
cell
prolifer
infiltr
human
cell
cell
b
cell
macrophag
although
ebvinfect
cell
found
synovi
membran
number
infect
cell
demonstr
bone
marrow
adjac
affect
joint
importantli
histolog
structur
term
pannu
characterist
ra
involv
destruct
bone
tissu
found
arthriti
lesion
hunog
mice
result
strongli
suggest
ebv
trigger
develop
eros
arthriti
resembl
ra
human
mice
sinc
studi
limit
histopatholog
analys
studi
pathogenesi
ebvinduc
arthriti
human
mous
model
necessari
possibl
involv
cytokin
includ
known
involv
pathogenesi
ra
readili
test
administr
specif
antibodi
indic
whether
arthriti
mice
gener
similar
mechan
human
ra
humor
immun
respons
ebv
ineffici
igm
antibodi
vca
compon
detect
virusinfect
hunog
mice
see
like
antigen
cross
reaction
ebv
protein
synovi
protein
play
critic
role
pathogenesi
arthriti
inde
rheumatoid
factor
antibodi
cyclic
citrullin
peptid
two
repres
marker
ra
detect
mice
present
arthriti
mechan
arthriti
format
shown
common
human
ebvinfect
mice
preclin
studi
therapeut
strategi
possibl
human
mice
analysi
immun
respons
ebv
infect
human
mice
made
possibl
develop
newgener
human
mice
reconstitut
human
b
cell
cell
dendrit
cell
achiev
brg
mice
transplant
human
hsc
describ
upon
infect
ebv
number
cell
significantli
increas
spleen
cell
isol
infect
mice
shown
prolifer
vigor
stimul
autolog
ebvtransform
lcl
although
ebv
specif
respons
confirm
blt
mice
develop
melku
other
presenc
human
thymu
tissu
enabl
restrict
cell
human
mhc
effici
ebvspecif
tcell
respons
demonstr
subsequ
pioneer
work
describ
ebvspecif
tcell
respons
studi
human
mice
variou
strain
ebvspecif
tcell
clone
phenotyp
establish
hunsg
mice
infect
viru
specif
lysi
hlamatch
lcl
demonstr
studi
confirm
antibodi
specif
human
classi
mhc
inhibit
product
cell
follow
stimul
autolog
lcl
indic
cell
isol
infect
mice
recogn
ebv
epitop
present
human
mhc
class
furthermor
human
mhc
class
tetram
present
ebv
epitop
identifi
ebvspecif
cell
hunog
mice
sinc
deplet
either
cell
administr
antibodi
respect
caus
aggress
prolifer
ebvinfect
cell
reduc
life
span
infect
mice
tcell
respons
induc
human
mice
thought
play
protect
role
one
studi
show
cell
isol
ebvinfect
mice
abil
suppress
transform
autolog
b
cell
ebv
induct
ebvspecif
tcell
respons
blt
mice
readili
accept
presenc
human
thymu
tissu
expect
allow
proper
select
cell
human
mhc
howev
tcell
respons
specif
ebv
demonstr
blt
mice
also
human
mice
without
transplant
human
thymu
tissu
furthermor
tcell
respons
specif
adenoviru
vector
express
hcg
glycoprotein
influenza
viru
demonstr
human
mice
without
human
thymic
tissu
sinc
posit
select
cell
thymu
thought
occur
surfac
epitheli
cell
epitheli
cell
human
mice
murin
origin
puzzl
cell
develop
capac
recogn
epitop
context
human
mhc
watanab
other
recogn
signific
delay
develop
human
cell
human
nog
mice
suggest
murin
mhc
involv
posit
select
human
cell
nevertheless
fact
develop
human
cell
retain
human
nog
mice
although
delay
reduc
number
suggest
human
hscderiv
cell
possibl
b
cell
dendrit
cell
also
involv
posit
select
human
cell
explain
tcell
respons
restrict
human
mhc
human
mice
one
way
clear
problem
tcell
educ
introduc
human
mhc
transgen
human
mice
two
nsgderiv
mous
strain
human
transgen
develop
transplant
hsc
hla
allel
human
mice
thu
obtain
mount
effici
tcell
respons
follow
ebv
infect
restrict
demonstr
although
test
ebv
infect
far
mous
transgen
shown
human
cell
control
mous
follow
reconstitut
hsc
antibodi
respons
ebv
analyz
hunog
mice
infect
ebv
compar
tcell
respons
antibodi
respons
much
less
effect
examin
infect
mice
three
mice
found
produc
igm
antibodi
major
compon
viral
capsid
antigen
vca
igg
antibodi
ebvencod
protein
detect
antibodi
respons
dengu
viru
also
describ
human
mice
although
igg
respons
report
dengu
viru
antibodi
respons
restrict
igm
ineffici
antibodi
respons
especi
igg
respons
probabl
due
intrins
defect
b
cell
human
mice
transfer
function
human
cell
express
tcr
specif
hemagglutinin
ha
improv
haspecif
igg
respons
hunog
mice
suggest
suboptim
interact
b
lymphocyt
underlay
ineffici
product
antigenspecif
igg
antibodi
hunog
mice
lack
human
follicular
dendrit
cell
human
mice
may
also
involv
ineffici
class
switch
ebv
infect
immunocompet
host
mostli
asymptomat
ebvinfect
lymphoblastoid
cell
potenti
unlimit
prolifer
effici
remov
virusspecif
ctl
express
highli
immunogen
protein
ebna
ebv
latenc
human
maintain
tcell
immunosurveil
ebv
resid
memori
b
cell
viral
protein
express
shut
render
invis
ctl
persist
infect
reminisc
ebv
latenc
human
reproduc
hunog
mice
inocul
low
dose
viru
major
hunog
mice
inocul
ebv
less
remain
normal
surviv
six
month
without
appar
sign
diseas
ebv
dna
detect
peripher
blood
transient
sever
week
follow
infect
mice
sacrif
six
month
postinfect
macroscop
patholog
chang
observ
yet
low
number
eberposit
cell
found
tissu
spleen
lymph
node
cell
shown
morpholog
rather
larg
cytoplasm
consist
rest
memori
b
cell
rtpcr
analysi
rna
obtain
spleen
liver
persist
infect
mice
show
express
consist
presenc
latenc
iii
cell
yajima
et
al
unpublish
result
thu
persist
ebv
infect
hunog
mice
appear
recapitul
aspect
ebv
latenc
human
sinc
number
defici
observ
function
b
cell
human
mice
reproduct
bone
fide
ebv
latenc
memori
b
cell
may
requir
sophist
human
mice
nevertheless
interest
question
immun
respons
involv
induct
mainten
persist
ebv
infect
hunog
mice
interestingli
ebv
dna
level
peripher
blood
fluctuat
persist
infect
mice
rise
ebv
dna
level
immedi
follow
increas
cell
subsequ
declin
ebv
dna
level
suggest
effect
tcell
control
ebvinfect
cell
trial
disrupt
persist
infect
immunosuppress
measur
induc
ebvassoci
lpd
underway
cocco
other
character
ebv
gene
express
surfac
marker
express
hypermut
immunoglobulin
variabl
region
singl
cell
level
lymphoid
tissu
human
brg
mice
infect
ebv
could
identifi
ebvinfect
cell
three
type
ebv
latenc
ii
iii
specif
correl
locat
tissu
presenc
hypermut
thu
exact
rout
ebv
establish
latent
infect
memori
b
cell
present
unclear
may
clarifi
experi
use
human
mice
among
nine
ebv
protein
two
set
untransl
rna
express
immort
lymphoblastoid
cell
shown
play
essenti
role
process
transform
wherea
knockingout
gene
homolog
recombin
affect
vitro
transform
abil
viru
viru
replic
affect
either
nevertheless
well
conserv
fresh
clinic
ebv
isol
critic
role
life
cycl
ebv
suppos
recent
work
white
other
demonstr
ebv
mutant
gene
knock
induc
aggress
lpd
hunsg
mice
suggest
function
tumor
suppressor
gene
b
cell
infect
mutant
viru
secret
less
tcell
chemoattract
therebi
escap
tcell
mediat
kill
may
thu
help
host
control
ebvinduc
lymphoprolifer
viru
give
lifethreaten
harm
host
find
possibl
vivo
experi
human
mice
point
import
area
applic
name
vivo
character
viru
mutant
immediateearli
gene
ebv
act
switch
latent
lytic
cycl
ebv
infect
knockingout
bzlf
gene
affect
viru
abil
transform
b
cell
vitro
involv
lymphomagenesi
expect
experi
human
mice
becam
feasibl
other
prepar
ebv
recombin
gene
knockedout
enhanc
express
compar
effici
lymphoma
genesi
blt
nsg
mice
result
clearli
indic
enhanc
lymphoma
genesi
induc
abort
lytic
infect
number
ebv
gene
encod
antiapoptot
protein
encod
ebv
thymidin
kinas
encod
viral
lossoffunct
mutant
exhibit
minor
phenotyp
alter
vitro
studi
examin
ebv
mutant
human
mice
may
reveal
critic
role
gene
ebv
life
cycl
pathogenesi
although
b
cell
major
target
ebv
group
diseas
term
ebvassoci
tnkcell
lpd
includ
caebv
ebvhlh
viru
mainli
found
nk
cell
prolifer
oligoclon
monoclon
caebv
character
prolong
imlik
symptom
unusu
pattern
antibodi
respons
ebv
elev
ebv
dna
load
peripher
blood
classif
lymphoma
caebv
correspond
larg
system
ebv
tcell
lymphoprolif
diseas
childhood
although
monoclon
prolifer
ebvinfect
cell
impli
malign
natur
diseas
chronic
clinic
time
cours
absenc
morpholog
atypia
prolifer
cell
contradict
notion
pathogenesi
diseas
larg
unresolv
overproduct
cytokin
ebvinfect
nk
cell
react
cell
macrophag
thought
respons
system
inflammatori
symptom
caebv
although
still
possibl
transform
human
nk
cell
vitro
ebv
establish
immort
cell
line
natur
diseas
strongli
suggest
specif
condit
ebv
infect
nk
cell
induc
prolifer
ebv
infect
nk
cell
reproduc
far
human
mice
recapitul
ebvassoci
tnk
lpd
mice
requir
xenotransplant
pbmc
deriv
patient
imadom
other
transplant
pbmc
isol
patient
caebv
ebvhlh
nog
mice
succeed
reproduc
major
featur
diseas
includ
system
monoclon
prolifer
ebvinfect
nk
cell
hypercytokinemia
mani
featur
common
caebv
ebvhlh
model
mice
find
hemorrhag
lesion
extrem
hypercytokinemia
uniqu
latter
model
importantli
model
reveal
essenti
role
cell
whether
infect
ebv
vivo
prolifer
ebvinfect
nk
cell
deplet
cell
administr
antibodi
follow
transplant
pbmc
effect
prevent
engraft
ebvinfect
cell
furthermor
administr
antibodi
engraft
ebvinfect
cell
reduc
peripher
blood
ebv
dna
load
undetect
level
imadom
other
unpublish
result
result
suggest
therapeut
approach
target
cell
may
possibl
ebv
implic
varieti
diseas
tabl
minor
fraction
recapitul
human
mice
effort
reproduc
remain
diseas
human
mice
need
made
recognit
eros
arthriti
resembl
ra
human
mice
ration
search
lesion
symptom
autoimmun
diseas
ebvinfect
human
mice
vari
condit
ebv
infect
human
mice
includ
viral
dose
viral
strain
rout
inocul
time
infect
transplant
hsc
well
modifi
protocol
prepar
human
mice
recapitul
addit
ebvassoci
diseas
may
possibl
variou
environment
host
factor
thought
involv
pathogenesi
ebvassoci
diseas
human
mice
may
power
tool
test
effect
cofactor
candid
vivo
exampl
effect
suppos
cofactor
endem
burkitt
lymphoma
malaria
infect
euphorbia
plant
might
test
human
mice
host
genet
factor
may
also
evalu
human
mice
diseas
ra
hla
polymorph
influenc
pathogenesi
prepar
human
mice
hsc
highrisk
polymorph
may
enhanc
pathogenesi
similarli
primari
immunodefici
specif
suscept
ebv
may
reproduc
prepar
human
mice
hsc
deriv
patient
ebv
transmit
oral
via
saliva
initi
step
infect
take
place
oropharyng
epithelium
lymphoid
tissu
adjac
epithelium
ebv
inocul
human
mice
far
howev
employ
intraven
intraperiton
rout
therefor
critic
earli
event
ebv
infect
may
reproduc
preliminari
trial
oral
inocul
ebv
hunog
mice
success
yajima
et
al
unpublish
result
sinc
human
epitheli
cell
present
human
mice
result
suggest
replic
epitheli
cell
essenti
step
primari
ebv
infect
sinc
oral
transmiss
critic
initi
step
primari
ebv
infect
may
direct
later
stage
ebv
infect
host
highli
desir
natur
rout
transmiss
reproduc
human
mice
human
ebv
infect
usual
asymptomat
symptom
im
appear
long
incub
period
week
therefor
extrem
difficult
find
individu
current
acut
primari
ebv
infect
period
suitabl
analysi
innat
immun
respons
context
human
mous
may
ideal
tool
critic
earli
innat
respons
ebv
might
reveal
human
mice
although
analyz
earli
event
follow
infect
one
studi
use
nodscid
mice
human
fetal
thymu
xenograft
focus
innat
immun
respons
ebv
demonstr
role
ebvinduc
nkt
cell
suppress
tumorigenesi
ebvassoci
hodgkin
lymphoma
nasopharyng
carcinoma
cell
effort
overcom
variou
limit
current
human
mous
model
underway
exampl
engraft
human
cell
improv
introduc
human
transgen
immunodefici
mous
strain
introduc
murin
gene
human
hsc
therebi
avoid
reject
murin
macrophag
improv
signal
murin
cytokin
growth
factor
gener
poorli
crossreact
human
receptor
supplement
human
equival
either
direct
inject
introduct
transgen
knockin
recombin
expect
improv
reconstitut
human
immun
system
compon
inde
supplement
human
cytokin
gmcsf
mcsf
epo
report
improv
develop
andor
mainten
certain
human
immun
system
compon
improv
protocol
well
introduct
human
mhc
transgen
describ
eventu
realiz
human
mice
capac
immun
respons
compar
human
evalu
vaccin
candid
includ
ebv
may
becom
feasibl
improv
human
mice
